Ref.: BO 01 020
ARTI-CELL FORTE INJ. SUSP. 2ML 1DS
Stem cells
If you have already registered, log in to GirovetPro
Description
PHARMACEUTICAL FORM
Injectable suspension. Suspension of allogeneic mesenchymal stem cells derived from equine peripheral blood induced by chondrogenesis: transparent and colorless suspension. Suspension of allogeneic equine plasma (diluent): transparent and yellow suspension.
SPECIES
Horses.
Injectable suspension. Suspension of allogeneic mesenchymal stem cells derived from equine peripheral blood induced by chondrogenesis: transparent and colorless suspension. Suspension of allogeneic equine plasma (diluent): transparent and yellow suspension.
SPECIES
Horses.
Indications
Reduction of mild to moderate lameness associated with non-septic joint inflammation in horses.
Dose / Application / Administration
Route of administration:
Intraarticular.
Dosage:
A single intraarticular injection of 1 dose (2ml) per animal.
The safety of this medication during pregnancy or lactation has not been proven. Use only in accordance with a benefit-risk assessment made by the responsible veterinarian.
*For more complete information, check the technical data sheet.
Intraarticular.
Dosage:
A single intraarticular injection of 1 dose (2ml) per animal.
The safety of this medication during pregnancy or lactation has not been proven. Use only in accordance with a benefit-risk assessment made by the responsible veterinarian.
*For more complete information, check the technical data sheet.
Composition
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each dose of 2ml contains:
Active substance (1ml):
Allogeneic mesenchymal stem cells derived from equine peripheral blood induced by chondrogenesis (1ml): 1,4–2,5 × 106
Excipients (1ml):
Equine allogeneic plasma: 1ml
Each dose of 2ml contains:
Active substance (1ml):
Allogeneic mesenchymal stem cells derived from equine peripheral blood induced by chondrogenesis (1ml): 1,4–2,5 × 106
Excipients (1ml):
Equine allogeneic plasma: 1ml
Presentation
2 ml
Laboratory
BOEHRINGER

Leave us your comment